Hyperion DeFi, Inc. (HYPD) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Hyperion DeFi, Inc. stock (HYPD) is currently trading at $3.41. Hyperion DeFi, Inc. PS ratio (Price-to-Sales) is 80.23. WallStSmart rates HYPD as Sell.
- HYPD PE ratio analysis and historical PE chart
- HYPD PS ratio (Price-to-Sales) history and trend
- HYPD intrinsic value — DCF, Graham Number, EPV models
- HYPD stock price prediction 2025 2026 2027 2028 2029 2030
- HYPD fair value vs current price
- HYPD insider transactions and insider buying
- Is HYPD undervalued or overvalued?
- Hyperion DeFi, Inc. financial analysis — revenue, earnings, cash flow
- HYPD Piotroski F-Score and Altman Z-Score
- HYPD analyst price target and Smart Rating
Hyperion DeFi, Inc.
📊 No data available
Try selecting a different time range
Smart Analysis
Hyperion DeFi, Inc. (HYPD) · 6 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/book. Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.
Hyperion DeFi, Inc. (HYPD) Key Strengths (1)
Trading below book value, meaning the market prices it less than net assets
Hyperion DeFi, Inc. (HYPD) Areas to Watch (5)
Company is destroying shareholder value
Losing money on operations
Very expensive at 80.2x annual revenue
Very low institutional interest at 8.13%
Micro-cap company with very limited liquidity and high volatility
Supporting Valuation Data
Hyperion DeFi, Inc. (HYPD) Detailed Analysis Report
Overall Assessment
This company scores 19/100 in our Smart Analysis, earning a F grade. Out of 6 metrics analyzed, 1 register as strengths (avg 10.0/10) while 5 fall into concern territory (avg 1.4/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Book. Valuation metrics including Price/Book (0.39) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Price/Sales. Some valuation metrics including Price/Sales (80.23) suggest expensive pricing. Profitability pressure is visible in Return on Equity at -228.70%, Operating Margin at -60667.00%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -228.70% needing improvement to support the investment thesis. Third, top-line growth trajectory.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
HYPD Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
HYPD's Price-to-Sales ratio of 80.23x trades at a deep discount to its historical average of 518.03x (59th percentile). The current valuation is 98% below its historical high of 4405.02x set in Feb 2024, and 10457% above its historical low of 0.76x in Oct 2023. Over the past 12 months, the PS ratio has compressed from ~194.5x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for Hyperion DeFi, Inc. (HYPD) · HEALTHCARE › BIOTECHNOLOGY
The Big Picture
Hyperion DeFi, Inc. operates as a stable business with moderate growth and solid fundamentals. Revenue reached 44,440 with 0% growth year-over-year. The company is currently unprofitable, posting a 0.0% profit margin.
Key Findings
Debt-to-equity ratio of 0.12 indicates a conservative balance sheet with 8M in cash.
Spending 841% of revenue (373,855) on R&D, reinforcing its commitment to innovation and future growth.
Free cash flow is -3M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Volatility is elevated with a beta of 2.78, so expect amplified moves relative to the broader market.
Sector dynamics: monitor BIOTECHNOLOGY industry trends, competitive moves, and regulatory changes that could impact Hyperion DeFi, Inc..
Bottom Line
Hyperion DeFi, Inc. offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Hyperion DeFi, Inc.(HYPD)
NASDAQ
HEALTHCARE
BIOTECHNOLOGY
USA
Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company is headquartered in New York, New York.